ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease"

  • Abstract Number: 1245 • 2012 ACR/ARHP Annual Meeting

    Age-Specific Association Between Disease-Related Measures and Incident Cardiovascular Events and All-Cause Mortality in Early Rheumatoid Arthritis

    Sofia Ajeganova1, Maria LE Andersson2, Johan Frostegård3 and Ingiäld Hafström1, 1Karolinska Institutet, Unit of Rheumatology, Department of Medicine Huddinge, Stockholm, Sweden, 2R&D Center, Spenshult Hospital, Oskarström, Sweden, 3Karolinska Institutet, Section of Immunology and chronic disease, Institute of Environmental Medicine, Stockholm, Sweden

    Background/Purpose: Increased risk of cardiovascular disease (CVD) and premature mortality in rheumatoid arthritis (RA) has been established, but the impact of inflammatory and disease related…
  • Abstract Number: 350 • 2012 ACR/ARHP Annual Meeting

    Reduction of Inflammation with Abatacept and Tocilizumab Results in Lower N-Terminal Pro Brain Natriuretic Peptide Levels in Patients with Rheumatoid Arthritis: Results From Prospective Cohort Studies

    Inge A.M. van den Oever and Mike T. Nurmohamed, Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk of heart failure (HF). The chronic inflammatory state in RA is associated with increased levels of…
  • Abstract Number: 1682 • 2012 ACR/ARHP Annual Meeting

    Sustained Clinical Remission (Disease Activity Score 28 <2.6) Protects for Cardiovascular Disease in Rheumatoid Arthritis Patients

    Elke.E.A. Arts1, Jaap Fransen2, Alfons A. den Broeder3, Calin Popa1 and Piet L.C.M. van Riel1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Chronic inflammation appears to be an independent risk factor for CVD in rheumatoid arthritis (RA), but there is no clear difference in CVD risk…
  • Abstract Number: 1253 • 2012 ACR/ARHP Annual Meeting

    Identifying Vulnerable Plaque in Rheumatoid Arthritis:  A Pilot Study Using Novel Microbubble-Contrast Enhanced Carotid Ultrasonography

    Kimberly P. Liang1, Douglas P. Landsittel2, Suresh R. Mulukutla3, Steven E. Reis4, Marc C. Levesque1, Flordeliza S. Villanueva3, Hunter C. Champion5 and Larry W. Moreland1, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Medicine, Biostatistics and Clinical and Translational Science, University of Pittsburgh, Center for Health Care Research Data Center, Pittsburgh, PA, 3Division of Cardiology, University of Pittsburgh, Pittsburgh, PA, 4Division of Cardiology and Department of Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, 5Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Rheumatoid arthritis (RA) is independently associated with a higher risk of cardiovascular disease (CVD). Markers of systemic inflammation, as seen in RA, are associated…
  • Abstract Number: 210 • 2012 ACR/ARHP Annual Meeting

    An Analysis of Metabolic Syndrome in Adult Dermatomyositis with a Focus On Cardiovascular Disease

    Mariana T. Moraes1, Fernando H.C. Souza2, Thiago B. M. Barros1 and Samuel K. Shinjo1, 1Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities associated with increased cardiovascular risk. MetS has been systematically evaluated in all systemic autoimmune rheumatic…
  • Abstract Number: 1686 • 2012 ACR/ARHP Annual Meeting

    Vertebral Fracture Assessment-Detected Abdominal Aortic Calcification Enhances Cardiovascular Disease Risk Stratification of Rheumatoid Arthritis Patients

    Ausaf Mohammad1, Derek Lohan2, Diane Bergin2, Sarah Mooney2, John Newell3, Martin O'Donnell4, Robert J. Coughlan1 and John J. Carey1, 1Rheumatology, Galway University Hospitals, Galway, Ireland, 2Radiology, Galway University Hospitals, Galway, Ireland, 3Clinical Research Facility, National University of Ireland, Galway, Ireland, 4Clinical Research Facility, Galway University Hospitals, Galway, Ireland

    Vertebral Fracture Assessment-detected Abdominal Aortic Calcification Enhances Cardiovascular Disease Risk Stratification of Rheumatoid Arthritis Patients Background/Purpose: Osteoporosis and cardiovascular disease (CVD) are major comorbidities and CVD…
  • Abstract Number: 1255 • 2012 ACR/ARHP Annual Meeting

    Vascular Calcification On Hand and Feet X-Rays, VFA Imaging of the Spine, and Cardiovascular Disease in Rheumatoid Arthritis

    Ausaf Mohammad1, Collette English2, Derek Lohan2, Diane Bergin2, Sarah Mooney2, John Newell3, Martin O'Donnell4, Robert J. Coughlan1 and John J. Carey1, 1Rheumatology, Galway University Hospitals, Galway, Ireland, 2Radiology, Galway University Hospitals, Galway, Ireland, 3Clinical Research Facility, National University of Ireland, Galway, Ireland, 4Clinical Research Facility, Galway University Hospitals, Galway, Ireland

    Vascular Calcification on Hand and Feet X-rays, VFA imaging of the spine, and Cardiovascular Disease in Rheumatoid ArthritisBackground/Purpose: Patients with rheumatoid arthritis (RA) are at…
  • Abstract Number: 161 • 2012 ACR/ARHP Annual Meeting

    Increased Serum Uric Acid: Consequence or Cause of Increased Cardiovascular Risk

    Inger L. Meek1, Harald E. Vonkeman2 and Mart A.F.J. van de Laar3, 1Rheumatology & Clinical Immunology, Rheumatology Center Twente, Medisch Spectrum Twente & Twente University, Enschede, Netherlands, 2Rheumatology Center Twente, Medisch Spectrum Twente & Twente University, Enschede, Netherlands, 3Rheumatology, Medisch Spectrum Twente & University of Twente, Enschede, Netherlands

    Background/Purpose: Reports on cardiovascular (CV) disease in hyperuricemia and gout show conflicting results. Some studies show hyperuricemia to be an independent risk factor for CV…
  • Abstract Number: 1668 • 2012 ACR/ARHP Annual Meeting

    Improving the Accuracy of Cardiovascular Risk Prediction in Rheumatoid Arthritis with a New Predictive Model Using the 10-Year Prospective Carre-Study

    Alper M. van Sijl1, Inge A.M. van den Oever1, Mike J.L. Peters2, Vokko P. van Halm3, Alexandre E. Voskuyl4, Yvo M. Smulders5 and Mike T. Nurmohamed1, 1Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 2Internal medicine, VU University Medical Center, Amsterdam, Netherlands, 3Cardiology, Academic Medical Centre, Amsterdam, Netherlands, 4Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 5Internal Medicine, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease which is associated with an increased cardiovascular (CV) risk. Traditional CV risk factors do not…
  • Abstract Number: 1198 • 2012 ACR/ARHP Annual Meeting

    Cardiovascular  Risk Factors and Events Are More Frequent Prior to the Onset of Rheumatoid Arthritis Than in the General Population

    Helen Pahau Sr.1, Vibeke Videm2, Sanjoy Paul3 and Ranjeny Thomas4, 1Diamantina Institute, University of Queensland Diamantina Institute, Brisbane, Australia, 2Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, and Department of Immunology and Transfusion Medicine, Trondheim University Hospital,, Trondheim, Norway, 3University of Queensland School of Population Health, Brisbane, Australia, 4University of Queensland Diamantina Institute, Brisbane, Australia

    Background/Purpose: Patients with the inflammatory autoimmune disease Rheumatoid Arthritis (RA) have a higher mortality and morbidity than the general population, predominantly related to cardiovascular disease…
  • Abstract Number: 165 • 2012 ACR/ARHP Annual Meeting

    Colchicine Is Associated with a Decreased Rate of Myocardial Infarction in Gout Patients: Interim Results From a Retrospective Cohort Study

    Daria B. Crittenden1, Cilian J. White1, Michael DeBerardine1, Grace Kim2, Binita Shah3, Jessica C. Kimmel1, Rima D. Patel1, Steven P. Sedlis3, Jeffrey D. Greenberg4, Craig T. Tenner5, Bruce N. Cronstein1 and Michael H. Pillinger1, 1Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY, 2NYU School of Medicine, Division of Rheumatology, New York, NY, 3NYU School of Medicine, Division of Cardiology, New York, NY, 4Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, 5Internal Medicine, NYU School of Medicine, Department of Internal Medicine, New York, NY

    Background/Purpose: Atherosclerosis is an inflammatory process, but to date no anti-inflammatory agent has definitively been shown to alter cardiovascular (CV) risk. Colchicine is an anti-inflammatory…
  • Abstract Number: 2568 • 2012 ACR/ARHP Annual Meeting

    The Risk of Pulmonary Embolism and Deep Vein Thrombosis in Giant Cell Arteritis: A Population-Based Cohort Study

    J. Antonio Avina-Zubieta1, Diane Lacaille2, Eric C. Sayre3, Jacek A. Kopec3 and Hyon Choi4, 1Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, 2Rheumatology, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Arthritis Research Centre of Canada/University of British Columbia, Boston, MA

    Background/Purpose: A recent hospital-based study has suggested an 8 fold increased risk of pulmonary embolism (PE) in individuals with polymyalgia rheumatica in the year following…
  • Abstract Number: 1651 • 2012 ACR/ARHP Annual Meeting

    Higher Corticosteroid Doses Early in Disease Have A Long-Term Influence On Metabolic Syndrome in Systemic Lupus Erythematosus: Data from an International Inception Cohort

    Ben Parker1, Murray B. Urowitz2, Dafna D. Gladman3, Mark Lunt4, Ian N. Bruce5 and Systemic Lupus International Collaborating Clinic (SLICC)6, 1Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 2Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 5Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit and NIHR Manchester Musculoskeletal Biomedical Research Unit, The University of Manchester, Manchester, United Kingdom, 6Toronto

    Background/Purpose: The Metabolic Syndrome (MetS) is a clustering of metabolic abnormalities associated with an increased risk of developing diabetes and atherosclerosis, and may add to…
  • Abstract Number: 872 • 2012 ACR/ARHP Annual Meeting

    Monocyte Chemoattractant Protein-1 and Eotaxin Are Associated with Parameters of Cardiac Dysfunction in Juvenile Dermatomyositis

    Thomas Schwartz1, Ivar Sjaastad2, Berit Flatø3, Maria Vistnes1, Geir Christensen1 and Helga Sanner3, 1Institute for Experimental Medical Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway, 2Institute for Clinical Medicine, University of Oslo, Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway, 3Department of Rheumatology, Oslo University Hospital, Institute for Clinical Medicine, University of Oslo, Oslo, Norway

    Background/Purpose : Juvenile dermatomyositis (JDM) is a vasculopathic disease affecting not only skeletal muscle and skin, but other organs as well. Previously we have shown…
  • Abstract Number: 68 • 2012 ACR/ARHP Annual Meeting

    Cardiovascular Comorbidities Antedating the Diagnosis of Rheumatoid Arthritis

    Anne M. Kerola1, Tuomas Kerola2, Markku J. Kauppi2, Hannu Kautiainen3, Lauri J. Virta4, Kari Puolakka5 and Tuomo Nieminen6, 1Medical School, University of Helsinki, Helsinki, Finland, 2Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 3Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, 4Research Department, the Social Insurance Institution, Turku, Finland, 5Department of Medicine, South Karelia Central Hospital, Lappeenranta, Finland, 6Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular morbidity. Evidence suggests that RA patients are at an increased risk of…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology